Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.860 -0.070 (-0.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts
U.S. Treasury yields have recently experienced a significant decline, with the benchmark 10-year Treasury note falling to its lowest levels since April 2025. This sharp dip in yields reflects a... 
Via MarketMinute
Topics Bonds Economy Supply Chain
Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
1 Surging Stock with Exciting Potential and 2 That Underwhelm
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
Via StockStory
4 Analysts Assess NeoGenomics: What You Need To Know
 
Via Benzinga
Earnings Outlook For NeoGenomics
 
Via Benzinga
Why Is NeoGenomics (NEO) Stock Soaring Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 22.5% in the morning session after a court ruled in the company's favor in a patent infringement lawsuit against Natera. 
Via StockStory
Topics Economy Intellectual Property Lawsuit
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims
NeoGenomics wins a North Carolina court ruling invalidating key Natera patents, clearing the way for its RaDaR ST assay and boosting investor sentiment. 
Via Benzinga
Topics Intellectual Property
Top movers in Friday's session
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
Earnings Scheduled For July 29, 2025
 
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
3 Healthcare Stocks with Open Questions
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Testing & Diagnostics Services Stocks Q2 Teardown: NeoGenomics (NASDAQ:NEO) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting... 
Via StockStory
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
NEO Q2 Deep Dive: Guidance Reset Amid Pharma Weakness, Delayed Product Launches
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 10.2% year on year to $181.3 million. The company’s full-year... 
Via StockStory
Why NeoGenomics (NEO) Stock Is Trading Up Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 4.8% in the afternoon session after news of a significant insider purchase by a key executive. The move followed the... 
Via StockStory
Earnings Scheduled For August 12, 2025
 
Via Benzinga
1 Small-Cap Stock with Exciting Potential and 2 We Ignore
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
A Glimpse Into The Expert Outlook On NeoGenomics Through 3 Analysts
 
Via Benzinga
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company reported second-quarter results that included a significant cut to its... 
Via StockStory
Topics Lawsuit
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8%
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 10.2% year on year to $181.3 million. The company’s full-year... 
Via StockStory
NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings this Tuesday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.